{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:49:49Z","timestamp":1774414189520,"version":"3.50.1"},"reference-count":223,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.prp.2023.154690","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T04:57:34Z","timestamp":1689569854000},"page":"154690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["The potential role of miRNAs in the pathogenesis of adrenocortical carcinoma \u2013 A focus on signaling pathways interplay"],"prefix":"10.1016","volume":"248","author":[{"given":"Heba M.","family":"Midan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gouda Kamel","family":"Helal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed I.","family":"Abulsoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shereen Saeid","family":"Elshaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A.","family":"El-Husseiny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doaa","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nourhan M.","family":"Abdelmaksoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif S.","family":"Abdel Mageed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed S.","family":"Elballal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Bakr","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai A.","family":"Abd-Elmawla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohada M.","family":"AL-Noshokaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nehal I.","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud A.","family":"Elrebehy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walaa A.","family":"El-Dakroury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr H.","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed S.","family":"Doghish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.prp.2023.154690_bib1","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.3390\/cancers15112873","article-title":"Preclinical models of adrenocortical cancer","volume":"15","author":"Sedlack","year":"2023","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.prp.2023.154690_bib2","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1073\/pnas.161479898","article-title":"An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma","volume":"98","author":"Ribeiro","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.prp.2023.154690_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical Carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib4","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"Ca Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.prp.2023.154690_bib5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W","article-title":"Adrenocortical carcinoma","volume":"88","author":"Wajchenberg","year":"2000","journal-title":"Cancer"},{"issue":"17","key":"10.1016\/j.prp.2023.154690_bib6","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199004263221705","article-title":"Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy","volume":"322","author":"Luton","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.prp.2023.154690_bib7","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1002\/1097-0142(19950515)75:10<2587::AID-CNCR2820751028>3.0.CO;2-5","article-title":"Adrenocortical carcinoma. A clinical study and treatment results of 52 patients","volume":"75","author":"Kasperlik-Zalu\u0142ska","year":"1995","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.prp.2023.154690_bib8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/BF02067349","article-title":"Adrenal cortical carcinoma in Norway, 1970\u20131984","volume":"16","author":"S\u00f8reide","year":"1992","journal-title":"World J. Surg."},{"issue":"2","key":"10.1016\/j.prp.2023.154690_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0022-5347(17)40734-8","article-title":"The cleveland clinic experience with adrenal cortical carcinoma","volume":"141","author":"Bodie","year":"1989","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.prp.2023.154690_bib10","first-page":"926","article-title":"Adrenal cortical carcinoma\u2014a continuing challenge","volume":"94","author":"Henley","year":"1983","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.prp.2023.154690_bib11","first-page":"963","article-title":"An eleven-year experience with adrenocortical carcinoma","volume":"112","author":"Pommier","year":"1992","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1200\/JCO.1990.8.1.67","article-title":"Adrenocortical carcinoma in children: a study of 40 cases","volume":"8","author":"Ribeiro","year":"1990","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/1097-0142(197907)44:1<239::AID-CNCR2820440139>3.0.CO;2-R","article-title":"Adrenal cortical carcinoma. A clinical and pathologic study of 49 cases","volume":"44","author":"King","year":"1979","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.prp.2023.154690_bib14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0002-9343(66)90219-1","article-title":"Adrenal cortical carcinoma: clinical features of 138 patients","volume":"41","author":"Hutter","year":"1966","journal-title":"Am. J. Med."},{"key":"10.1016\/j.prp.2023.154690_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/381917","article-title":"MicroRNA era: the importance for diagnosis and prognosis of adrenocortical tumors","volume":"2014","author":"Bezerra","year":"2014","journal-title":"BioMed. Res. Int."},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib16","first-page":"73","article-title":"MicroRNA-499 gene expression in Egyptian type 2 diabetes mellitus patients with and without coronary heart disease","volume":"2","author":"Oraby","year":"2022","journal-title":"Azhar Int. J. Pharm. Med. Sci."},{"key":"10.1016\/j.prp.2023.154690_bib17","article-title":"Association of miRNA-499 rs3746444 A> G genotype variants with type 2 diabetes mellitus and its coronary heart disease complication in adult Egyptian population","volume":"29","author":"Oraby","year":"2022","journal-title":"Gene Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib18","article-title":"MiR-216a in diabetic nephropathy: relation with autophagy and apoptosis","volume":"7","author":"Elshaer","year":"2018","journal-title":"Int. J. Pharm. Res. Allied Sci."},{"issue":"10","key":"10.1016\/j.prp.2023.154690_bib19","doi-asserted-by":"crossref","first-page":"FSO829","DOI":"10.2144\/fsoa-2022-0074","article-title":"The expression profiling of serum miR-92a, miR-134 and miR-375 in acute ischemic stroke","volume":"8","author":"Salman","year":"2022","journal-title":"Future Sci. OA"},{"key":"10.1016\/j.prp.2023.154690_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijbiomac.2021.12.141","article-title":"A review of the biological role of miRNAs in prostate cancer suppression and progression","volume":"197","author":"Doghish","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154690_bib21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijbiomac.2022.06.134","article-title":"miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: a spotlight on signaling pathways interplay\u2014a review","volume":"214","author":"Elrebehy","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154690_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153886","article-title":"miRNAs inspirations in hepatocellular carcinoma: detrimental and favorable aspects of key performers","author":"El-Mahdy","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120923","article-title":"Megalin, a multi-ligand endocytic receptor, and its participation in renal function and diseases: a review","author":"Elsakka","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154690_bib24","article-title":"Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: a comprehensive review","author":"Ismail","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154690_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154222","article-title":"The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance-a focus on signaling pathways interplay","author":"Ismail","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154510","article-title":"The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance \u2013 a focus on signaling pathways interplay","volume":"246","author":"Hegazy","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154053","article-title":"A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: a focus on signaling pathways interplay","author":"Doghish","year":"2022","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154316","article-title":"miRNAs role in bladder cancer pathogenesis and targeted therapy: signaling pathways interplay-a review","author":"El-Mahdy","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib29","article-title":"miRNAs role in cervical cancer pathogenesis and targeted therapy: signaling pathways interplay","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154371","article-title":"Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib31","article-title":"miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance\u2013an emphasis on the interaction of signaling pathways","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154411","article-title":"The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways","author":"Abdelmaksoud","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154424","article-title":"miRNAs as potential game-changers in melanoma: a comprehensive review","author":"Abd-Allah","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154437","article-title":"The interplay of signaling pathways with miRNAs in cholangiocarcinoma pathogenicity and targeted therapy","author":"Zaki","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121667","article-title":"An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer","author":"Fathi","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154690_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154438","article-title":"Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance-a review","author":"Al-Noshokaty","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib37","article-title":"A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154439","article-title":"miRNAs as potential game-changers in renal cell carcinoma: future clinical and medicinal uses","volume":"245","author":"Elballal","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154457","article-title":"miRNAs as potential game-changers in head and neck cancer: future clinical and medicinal uses","author":"El-Mahdy","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121697","article-title":"Androgen receptor blockade by flutamide down-regulates renal fibrosis, inflammation, and apoptosis pathways in male rats","volume":"323","author":"Allam","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154690_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105195","article-title":"Impact of the mother's gut microbiota on infant microbiome and brain development","author":"Mady","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.prp.2023.154690_bib42","article-title":"The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154511","article-title":"miRNAs role in glioblastoma pathogenesis and targeted therapy: signaling pathways interplay","author":"Elshaer","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154557","article-title":"miR-509-5p promotes colorectal cancer cell ferroptosis by targeting SLC7A11","author":"Elrebehy","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib45","article-title":"miRNAs as potential game-changers in retinoblastoma: future clinical and medicinal uses","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154584","article-title":"The potential role of miRNAs in the pathogenesis of salivary gland cancer \u2013 a focus on signaling pathways interplay","volume":"247","author":"Abulsoud","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib47","article-title":"miRNAs orchestration of salivary gland cancer- particular emphasis on diagnosis, progression, and drug resistance","author":"Ahmed","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib48","article-title":"The potential role of miRNAs in the pathogenesis of testicular germ cell tumors - a focus on signaling pathways interplay","author":"Doghish","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154612","article-title":"miRNAs orchestration of testicular germ cell tumors - particular emphasis on diagnosis, progression and drug resistance","author":"Elesawy","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154665","article-title":"miRNAs orchestration of adrenocortical carcinoma - particular emphasis on diagnosis, progression and drug resistance","author":"El-Dakroury","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib51","article-title":"The potential role of miRNAs in the pathogenesis of gallbladder cancer - a focus on signaling pathways interplay","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154375","article-title":"The role of miRNAs in liver diseases: potential therapeutic and clinical applications","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib53","article-title":"miRNAs as potential game-changers in bone diseases: future medicinal and clinical Uses","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154613","article-title":"miRNAs orchestration of cardiovascular diseases \u2013 particular emphasis on diagnosis, and progression","volume":"248","author":"Elsakka","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib55","article-title":"The potential role of miRNAs in the pathogenesis of cardiovascular diseases \u2013 a focus on signaling pathways interplay","volume":"248","author":"Khidr","year":"2023","journal-title":"Pathol.\u00a0Res. Pract."},{"issue":"4","key":"10.1016\/j.prp.2023.154690_bib56","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/j.sjbs.2021.02.001","article-title":"MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8","volume":"28","author":"Elkady","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.prp.2023.154690_bib57","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/DMSO.S187422","article-title":"Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients","author":"Bakr Zaki","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"issue":"7","key":"10.1016\/j.prp.2023.154690_bib58","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jcjd.2020.12.005","article-title":"Circulating miR-148a-5p and miR-21-5p as novel diagnostic biomarkers in adult egyptian male patients with metabolic syndrome","volume":"45","author":"Doghish","year":"2021","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.prp.2023.154690_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121321","article-title":"miRNAs insights into rheumatoid arthritis: favorable and detrimental aspects of key performers","volume":"314","author":"Doghish","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154690_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154512","article-title":"Long non-coding RNAs and rheumatoid arthritis: pathogenesis and clinical implications","author":"Elazazy","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2022.106978","article-title":"miRNAs as cornerstones in diabetic microvascular complications","volume":"138","author":"Ismail","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.prp.2023.154690_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123189","article-title":"The role of miRNAs in insulin resistance and diabetic macrovascular complications \u2013 a review","volume":"230","author":"Abdel Mageed","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154690_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121382","article-title":"miRNAs as cornerstones in adipogenesis and obesity","volume":"315","author":"Elkhawaga","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib64","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.dsx.2018.11.058","article-title":"Plasma endoglin in Type2 diabetic patients with nephropathy","volume":"13","author":"Doghish","year":"2019","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"issue":"10","key":"10.1016\/j.prp.2023.154690_bib65","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/cbin.11653","article-title":"miRNAs; a novel strategy for the treatment of COVID\u201019","volume":"45","author":"Ying","year":"2021","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.prp.2023.154690_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113977","article-title":"Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions","volume":"157","author":"Abulsoud","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.prp.2023.154690_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271271","article-title":"Clinical and chest computed tomography features of patients suffering from mild and severe COVID-19 at Fayoum University Hospital in Egypt","volume":"17","author":"Ismail","year":"2022","journal-title":"Plos One"},{"issue":"4","key":"10.1016\/j.prp.2023.154690_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249346","article-title":"Clinical characteristics of Egyptian male patients with COVID\u201019 acute respiratory distress syndrome","volume":"16","author":"Doghish","year":"2021","journal-title":"Plos One"},{"key":"10.1016\/j.prp.2023.154690_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112681","article-title":"MicroRNAs in Alzheimer's disease: potential diagnostic markers and therapeutic targets","volume":"148","author":"Liu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2023.154690_bib70","unstructured":"K.I. Eissa, M.M. Kamel, L.W. Mohamed, A.S. Doghish, R. Alnajjar, A.A. Al\u2010Karmalawy, A.E. Kassab, Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease, Drug Dev. Res."},{"key":"10.1016\/j.prp.2023.154690_bib71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.acr.2017.06.001","article-title":"The Enigma of miRNA regulation in cancer","volume":"135","author":"Pradhan","year":"2017","journal-title":"Adv. Cancer Res"},{"issue":"2","key":"10.1016\/j.prp.2023.154690_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020461","article-title":"Non-coding RNAs in adrenocortical cancer: from pathogenesis to diagnosis","volume":"12","author":"Decmann","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib73","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.surg.2022.08.025","article-title":"Multi-genomic analysis of 260 adrenocortical cancer patient tumors identifies novel network BIRC5-hsa-miR-335-5p-PAX8-AS1 strongly associated with poor survival","volume":"173","author":"Subramanian","year":"2023","journal-title":"Surgery"},{"key":"10.1016\/j.prp.2023.154690_bib74","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3389\/fgene.2019.00626","article-title":"Circulating MicroRNAs in cancer: potential and challenge","volume":"10","author":"Cui","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.prp.2023.154690_bib75","article-title":"Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway(s) and clinical outcome(s) association","volume":"240","author":"El-Sheikh","year":"2022","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2023.154690_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2022.09.209","article-title":"Interactome battling of lncRNA CCDC144NL-AS1: its role in the emergence and ferocity of cancer and beyond","author":"Abd El Fattah","year":"2022","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154690_bib77","article-title":"Defining disease-related modules based on weighted miRNA synergistic network","volume":"152","author":"Li","year":"2022","journal-title":"Comput. Biol. Med"},{"issue":"3","key":"10.1016\/j.prp.2023.154690_bib78","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ncrna.2023.03.004","article-title":"Telomerase RNA component lncRNA as potential diagnostic biomarker promotes CRC cellular migration and apoptosis evasion via modulation of \u03b2-catenin protein level","volume":"8","author":"Bakr","year":"2023","journal-title":"Non-coding RNA Res."},{"key":"10.1016\/j.prp.2023.154690_bib79","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mgene.2018.11.006","article-title":"Diagnostic significance of miR-639 and miR-10b in \u03b2reast cancer patients","volume":"19","author":"Ismail","year":"2019","journal-title":"Meta Gene"},{"issue":"7014","key":"10.1016\/j.prp.2023.154690_bib80","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","article-title":"Processing of primary microRNAs by the microprocessor complex","volume":"432","author":"Denli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.prp.2023.154690_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2022.08.002","article-title":"Mitochondrial miRNAs (MitomiRs): their potential roles in breast and other cancers","author":"Erturk","year":"2022","journal-title":"Mitochondrion"},{"issue":"10","key":"10.1016\/j.prp.2023.154690_bib82","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41477-021-01000-1","article-title":"Structural basis of microRNA processing by Dicer-like 1","volume":"7","author":"Wei","year":"2021","journal-title":"Nat. Plants"},{"issue":"11","key":"10.1016\/j.prp.2023.154690_bib83","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1101\/gad.1919710","article-title":"Emerging paradigms of regulated microRNA processing","volume":"24","author":"Newman","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2023.154690_bib84","first-page":"1","article-title":"Regulation of microRNAs, miRNomics","author":"Ergin","year":"2022","journal-title":"Springer"},{"issue":"7149","key":"10.1016\/j.prp.2023.154690_bib85","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05983","article-title":"Intronic microRNA precursors that bypass Drosha processing","volume":"448","author":"Ruby","year":"2007","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.prp.2023.154690_bib86","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1101\/gad.1705308","article-title":"Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs","volume":"22","author":"Babiarz","year":"2008","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib87","doi-asserted-by":"crossref","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2023.154690_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154567","article-title":"The long non-coding RNA ZFAS1 promotes colorectal cancer progression via miR200b\/ZEB1 axis","volume":"247","author":"Salman","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154570","article-title":"LncRNA NNT-AS1\/hsa-miR-485\u20135p\/HSP90 axis in-silico and clinical prospect correlated-to histologic grades-based CRC stratification: a step toward ncRNA Precision","volume":"247","author":"El-Sheikh","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154509","article-title":"Mitochondrial remodeling in colorectal cancer initiation, progression, metastasis, and therapy: a review","volume":"246","author":"Abdelmaksoud","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"4","key":"10.1016\/j.prp.2023.154690_bib91","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.tig.2021.10.002","article-title":"Classical and noncanonical functions of miRNAs in cancers","volume":"38","author":"Dragomir","year":"2022","journal-title":"Trends Genet"},{"key":"10.1016\/j.prp.2023.154690_bib92","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijbiomac.2021.12.141","article-title":"A review of the biological role of miRNAs in prostate cancer suppression and progression","volume":"197","author":"Doghish","year":"2022","journal-title":"Int J. Biol. Macromol."},{"issue":"7795","key":"10.1016\/j.prp.2023.154690_bib93","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41586-020-1996-3","article-title":"Loss of p53 drives neuron reprogramming in head and neck cancer","volume":"578","author":"Amit","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.prp.2023.154690_bib94","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ng2079","article-title":"Target mimicry provides a new mechanism for regulation of microRNA activity","volume":"39","author":"Franco-Zorrilla","year":"2007","journal-title":"Nat. Genet"},{"issue":"9","key":"10.1016\/j.prp.2023.154690_bib95","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nmeth1079","article-title":"MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells","volume":"4","author":"Ebert","year":"2007","journal-title":"Nat. Methods"},{"key":"10.1016\/j.prp.2023.154690_bib96","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.addr.2014.10.029","article-title":"Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics","volume":"81","author":"Yang","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.prp.2023.154690_bib97","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ccr.2007.10.028","article-title":"p53 enters the microRNA world","volume":"12","author":"Hermeking","year":"2007","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.prp.2023.154690_bib98","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2023.154690_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120675","article-title":"Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-\u03baB pathways and LncRNA-AF085935\/GPC3 axis","author":"Al-Noshokaty","year":"2022","journal-title":"J. Life Sci."},{"key":"10.1016\/j.prp.2023.154690_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120325","article-title":"Exosomal-long non-coding RNAs journey in colorectal cancer: evil and goodness faces of key players","volume":"292","author":"Rizk","year":"2022","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.prp.2023.154690_bib101","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bj.2020.03.001","article-title":"The role of miRNA biogenesis and DDX17 in tumorigenesis and cancer stemness","volume":"43","author":"Wu","year":"2020","journal-title":"Biomed. J."},{"issue":"6","key":"10.1016\/j.prp.2023.154690_bib102","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3390\/cells8060528","article-title":"Hypoxia- and MicroRNA-induced metabolic reprogramming of tumor-initiating cells","volume":"8","author":"Ullmann","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.prp.2023.154690_bib103","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mce.2016.12.005","article-title":"Cell signaling pathways in the adrenal cortex: links to stem\/progenitor biology and neoplasia","volume":"445","author":"Penny","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"issue":"14","key":"10.1016\/j.prp.2023.154690_bib104","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.3390\/cells11142234","article-title":"MicroRNAs and long non-coding RNAs in adrenocortical carcinoma","volume":"11","author":"Detomas","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1677\/joe.0.1780149","article-title":"Zonal expression of dickkopf-3 and components of the Wnt signalling pathways in the human adrenal cortex","volume":"178","author":"Suwa","year":"2003","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.prp.2023.154690_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119018","article-title":"Role of sodium glucose cotransporter type 2 inhibitors dapagliflozin on diabetic nephropathy in rats; Inflammation, angiogenesis and apoptosis","volume":"280","author":"Elkazzaz","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib107","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib108","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jcp.30561","article-title":"The multidimensional role of the Wnt\/\u03b2\u2010catenin signaling pathway in human malignancies","volume":"237","author":"Hiremath","year":"2022","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib109","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/nyas.14027","article-title":"The Wnt signaling pathway: a potential therapeutic target against cancer","volume":"1443","author":"Ghosh","year":"2019","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"17","key":"10.1016\/j.prp.2023.154690_bib110","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-05-0593","article-title":"Mutations of \u03b2-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors","volume":"65","author":"Tissier","year":"2005","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.prp.2023.154690_bib111","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1158\/0008-5472.CAN-09-0155","article-title":"MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of Wnt signaling","volume":"69","author":"Iliopoulos","year":"2009","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2023.154690_bib112","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1365-2265.2009.03725.x","article-title":"MicroRNA signature in massive macronodular adrenocortical disease and implications for adrenocortical tumourigenesis","volume":"72","author":"Bimpaki","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.prp.2023.154690_bib113","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.genrep.2016.09.001","article-title":"Matrix metalloproteinase (MMP)-2\u20131306\u2009C> T gene polymorphism affects circulating levels of MMP-2 in Egyptian asthmatic patients","volume":"5","author":"Elkady","year":"2016","journal-title":"Gene Rep."},{"issue":"18","key":"10.1016\/j.prp.2023.154690_bib114","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1158\/1078-0432.CCR-09-0049","article-title":"The multifaceted role of MTDH\/AEG-1 in cancer progressionMTDH\/AEG-1 in tumor progression","volume":"15","author":"Hu","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2023.154690_bib115","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1677\/ERC-09-0096","article-title":"Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis","volume":"16","author":"T\u00f6mb\u00f6l","year":"2009","journal-title":"Endocr. -Relat. Cancer"},{"key":"10.1016\/j.prp.2023.154690_bib116","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.fob.2015.11.001","article-title":"MicroRNA-431 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the ZEB1-mediated epithelial\u2013mensenchymal transition","volume":"5","author":"Sun","year":"2015","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.prp.2023.154690_bib117","article-title":"miRNAs role in glioblastoma pathogenesis and targeted therapy: signaling pathways interplay","volume":"246","author":"Elshaer","year":"2023","journal-title":"Pathol. Res. Pr."},{"issue":"12","key":"10.1016\/j.prp.2023.154690_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8120551","article-title":"Medical approaches in adrenocortical carcinoma","volume":"8","author":"Paragliola","year":"2020","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.prp.2023.154690_bib119","article-title":"miR-146 and miR-155: two key modulators of immune response and tumor development","volume":"3","author":"Testa","year":"2017","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.prp.2023.154690_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110099","article-title":"The dual role of mir-146a in metastasis and disease progression","volume":"126","author":"Shahriar","year":"2020","journal-title":"Biomed. Pharm."},{"issue":"5","key":"10.1016\/j.prp.2023.154690_bib121","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1016\/j.ygeno.2020.03.022","article-title":"Effect of scopoletin on phagocytic activity of U937-derived human macrophages: insights from transcriptomic analysis","volume":"112","author":"Alkorashy","year":"2020","journal-title":"Genomics"},{"issue":"3\u20134","key":"10.1016\/j.prp.2023.154690_bib122","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41417-020-00210-7","article-title":"Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy","volume":"28","author":"Karimzadeh","year":"2021","journal-title":"Cancer Gene Ther."},{"issue":"6","key":"10.1016\/j.prp.2023.154690_bib123","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/jir.2018.0155","article-title":"MicroRNA-155: a master regulator of inflammation","volume":"39","author":"Mahesh","year":"2019","journal-title":"J. Interferon Cytokine Res"},{"key":"10.1016\/j.prp.2023.154690_bib124","article-title":"The potential role of miRNAs in the pathogenesis of salivary gland cancer - a focus on signaling pathways interplay","volume":"247","author":"Abulsoud","year":"2023","journal-title":"Pathol. Res Pr."},{"issue":"16","key":"10.1016\/j.prp.2023.154690_bib125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169091","article-title":"Role of MicroRNA-7 (MiR-7) in cancer physiopathology","volume":"23","author":"Morales-Martinez","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.prp.2023.154690_bib126","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.495","article-title":"Alternative mechanisms of miR-34a regulation in cancer","volume":"8","author":"Slabakova","year":"2017","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.prp.2023.154690_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082198","article-title":"Key MicroRNA's and their targetome in adrenocortical cancer","volume":"12","author":"Chehade","year":"2020","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.prp.2023.154690_bib128","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040895","article-title":"Tissue miRNA combinations for the differential diagnosis of adrenocortical carcinoma and adenoma established by artificial intelligence","volume":"14","author":"Turai","year":"2022","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.prp.2023.154690_bib129","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1530\/EC-19-0114","article-title":"Apoptosis regulation in adrenocortical carcinoma","volume":"8","author":"Pereira","year":"2019","journal-title":"Endocr. Connect"},{"key":"10.1016\/j.prp.2023.154690_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154584","article-title":"The potential role of miRNAs in the pathogenesis of salivary gland cancer-\/ocus on signaling pathways interplay","author":"Abulsoud","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib131","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/ijms22010173","article-title":"PI3K\/AKT\/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects","volume":"22","author":"Miricescu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.154690_bib132","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00210-020-01957-4","article-title":"Cardioprotective role of GTS-21 by attenuating the TLR4\/NF-\u03baB pathway in streptozotocin-induced diabetic cardiomyopathy in rats","volume":"394","author":"Youssef","year":"2021","journal-title":"Naunyn-Schmiede 'S. Arch. Pharmacol."},{"issue":"7","key":"10.1016\/j.prp.2023.154690_bib133","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/PAI.0000000000000117","article-title":"Specific microRNAs differentiate adrenocortical adenomas from carcinomas and correlate with weiss histopathologic system","volume":"23","author":"Feinmesser","year":"2015","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"11","key":"10.1016\/j.prp.2023.154690_bib134","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1158\/0008-5472.CAN-09-3970","article-title":"Regulation of insulin-like growth factor\u2013mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors","volume":"70","author":"Doghman","year":"2010","journal-title":"Cancer Res."},{"issue":"48","key":"10.1016\/j.prp.2023.154690_bib135","doi-asserted-by":"crossref","first-page":"73001","DOI":"10.1007\/s11356-022-20734-9","article-title":"Cadmium induces apoptosis by miR-9-5p targeting PTEN and regulates the PI3K\/AKT pathway in the piglet adrenal gland","volume":"29","author":"Qi","year":"2022","journal-title":"Environ. Sci. Pollut. Res."},{"issue":"8","key":"10.1016\/j.prp.2023.154690_bib136","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.3390\/ijms24087513","article-title":"Impact of adipose tissue depot harvesting site on the multilineage induction capacity of male rat adipose-derived mesenchymal stem cells: an in vitro study","volume":"24","author":"El-Husseiny","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-021-02396-8","article-title":"p53 signaling in cancer progression and therapy","volume":"21","author":"Marei","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"6","key":"10.1016\/j.prp.2023.154690_bib138","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.3892\/or.2015.4295","article-title":"MicroRNA-205 suppresses the growth of adrenocortical carcinoma SW-13 cells via targeting Bcl-2","volume":"34","author":"Wu","year":"2015","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-015-0259-0","article-title":"MicroRNA-7: a promising new target in cancer therapy","volume":"15","author":"Zhao","year":"2015","journal-title":"Cancer Cell Int."},{"issue":"6","key":"10.1016\/j.prp.2023.154690_bib140","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1530\/ERC-11-0082","article-title":"The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma","volume":"18","author":"\u00d6zata","year":"2011","journal-title":"Endocr. -Relat. Cancer"},{"issue":"34","key":"10.1016\/j.prp.2023.154690_bib141","doi-asserted-by":"crossref","first-page":"36675","DOI":"10.18632\/oncotarget.5383","article-title":"MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma","volume":"6","author":"Glover","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.prp.2023.154690_bib142","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1210\/en.2007-1686","article-title":"Microribonucleic acid-21 increases aldosterone secretion and proliferation in H295R human adrenocortical cells","volume":"149","author":"Romero","year":"2008","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.prp.2023.154690_bib143","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1158\/0008-5472.CAN-23-0296","article-title":"KRAS Hijacks the miRNA regulatory pathway in cancer","volume":"83","author":"Bortoletto","year":"2023","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.prp.2023.154690_bib144","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/modpathol.2010.164","article-title":"MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas","volume":"23","author":"T\u00f6mb\u00f6l","year":"2010","journal-title":"Mod. Pathol."},{"issue":"7","key":"10.1016\/j.prp.2023.154690_bib145","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3390\/cancers13071522","article-title":"MicroRNAs, long non-coding RNAs, and circular RNAs: potential biomarkers and therapeutic targets in pheochromocytoma\/paraganglioma","volume":"13","author":"Turai","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2023.154690_bib146","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/B978-0-12-394622-5.00017-1","article-title":"Sonic Hedgehog signaling and potential therapeutic indications","volume":"88","author":"Bambakidis","year":"2012","journal-title":"Vitam. Horm."},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib147","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nrendo.2014.166","article-title":"Regulation of the adrenocortical stem cell niche: implications for disease","volume":"11","author":"Walczak","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.prp.2023.154690_bib148","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1210\/en.2009-0814","article-title":"Progenitor cell expansion and organ size of mouse adrenal is regulated by sonic hedgehog","volume":"151","author":"Huang","year":"2010","journal-title":"Endocrinology"},{"issue":"26","key":"10.1016\/j.prp.2023.154690_bib149","doi-asserted-by":"crossref","first-page":"22724","DOI":"10.18632\/oncotarget.4261","article-title":"Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma","volume":"6","author":"de Sousa","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154690_bib150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tiv.2017.02.012","article-title":"An integrative transcriptomic analysis reveals bisphenol A exposure-induced dysregulation of microRNA expression in human endometrial cells","volume":"41","author":"Chou","year":"2017","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.prp.2023.154690_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101245","article-title":"Insulin-like growth factors: ligands, binding proteins, and receptors","volume":"52","author":"LeRoith","year":"2021","journal-title":"Mol. Metab."},{"issue":"6","key":"10.1016\/j.prp.2023.154690_bib152","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s10637-021-01148-9","article-title":"The biological function of IGF2BPs and their role in tumorigenesis","volume":"39","author":"Du","year":"2021","journal-title":"Invest N. Drugs"},{"key":"10.1016\/j.prp.2023.154690_bib153","first-page":"195","article-title":"microRNAs as potential biomarkers in adrenocortical cancer: progress and challenges","volume":"6","author":"Cherradi","year":"2015","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"9","key":"10.1016\/j.prp.2023.154690_bib154","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41574-019-0221-7","article-title":"Adrenocortical carcinoma - towards genomics guided clinical care","volume":"15","author":"Crona","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"6","key":"10.1016\/j.prp.2023.154690_bib155","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.surg.2013.06.022","article-title":"MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors","volume":"154","author":"Patel","year":"2013","journal-title":"Surgery"},{"issue":"11","key":"10.1016\/j.prp.2023.154690_bib156","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/14728222.2018.1535594","article-title":"Let-7 microRNA as a potential therapeutic target with implications for immunotherapy","volume":"22","author":"Gilles","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib157","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/beta-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.prp.2023.154690_bib158","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fgene.2012.00120","article-title":"miR-34 - a microRNA replacement therapy is headed to the clinic","volume":"3","author":"Bader","year":"2012","journal-title":"Front Genet"},{"key":"10.1016\/j.prp.2023.154690_bib159","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3389\/fgene.2019.00525","article-title":"The Wnt\/beta-Catenin\/LEF1 pathway promotes cell proliferation at least in part through direct upregulation of miR-17-92 cluster","volume":"10","author":"Mu","year":"2019","journal-title":"Front Genet"},{"issue":"8","key":"10.1016\/j.prp.2023.154690_bib160","doi-asserted-by":"crossref","first-page":"14089","DOI":"10.18632\/oncotarget.12923","article-title":"The crosstalk between microRNAs and the Wnt\/beta-catenin signaling pathway in cancer","volume":"8","author":"Peng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154690_bib161","doi-asserted-by":"crossref","DOI":"10.1007\/s13277-016-5385-3","article-title":"Diverse roles of miR-335 in development and progression of cancers","author":"Luo","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.prp.2023.154690_bib162","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.2147\/OTT.S183600","article-title":"MicroRNA-195: a review of its role in cancers","volume":"11","author":"Yu","year":"2018","journal-title":"Oncol. Targets Ther."},{"issue":"3","key":"10.1016\/j.prp.2023.154690_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101434","article-title":"Next-generation therapies for adrenocortical carcinoma","volume":"34","author":"Altieri","year":"2020","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.prp.2023.154690_bib164","first-page":"953","article-title":"Protective effect of proanthocyanidins on nephrotoxicity induced by antitumor dose of cisplatin in ehrlich solid tumor-bearing mice","volume":"40","author":"Salman","year":"2014","journal-title":"Arab. J. Lab. Med"},{"issue":"2","key":"10.1016\/j.prp.2023.154690_bib165","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3390\/cancers12020508","article-title":"Adjuvant therapy in adrenocortical carcinoma: reflections and future directions","volume":"12","author":"Bedrose","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2023.154690_bib166","unstructured":"D.F. Maluf, B.H. de Oliveira, E. Lalli, Therapy of adrenocortical cancer: present and future, American journal of cancer research 1(2) (2011) 222."},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib167","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-017-0004-3","article-title":"Controlled drug delivery vehicles for cancer treatment and their performance","volume":"3","author":"Senapati","year":"2018","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2023.154690_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121364","article-title":"The neuroprotective effect of pterostilbene on oxaliplatin-induced peripheral neuropathy via its anti-inflammatory, anti-oxidative and anti-apoptotic effects: comparative study with celecoxib","author":"Abd-Elmawla","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154690_bib169","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","article-title":"MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside","volume":"15","author":"Ratti","year":"2020","journal-title":"Target. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib170","article-title":"Innovative approaches in transforming microRNAs into therapeutic tools","volume":"14","author":"Samad","year":"2023","journal-title":"Wiley Interdiscip. Rev.: RNA"},{"issue":"6","key":"10.1016\/j.prp.2023.154690_bib171","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1021\/acschemneuro.2c00653","article-title":"MAGI2-AS3 and miR-374b-5p as putative regulators of multiple sclerosis via modulating the PTEN\/AKT\/IRF-3\/IFN-\u03b2 axis: new clinical insights","volume":"14","author":"Kortam","year":"2023","journal-title":"ACS Chem. Neurosci."},{"issue":"11","key":"10.1016\/j.prp.2023.154690_bib172","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22899","article-title":"Lutein exerts its cardioprotective effect against the experimental model of isoprenaline\u2010induced myocardial infarction via MIAT\/miR\u2010200a\/Nrf2\/TXINP pathway","volume":"35","author":"Abdelmonem","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"4","key":"10.1016\/j.prp.2023.154690_bib173","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/wrna.1229","article-title":"MicroRNAs as therapeutic targets in human cancers","volume":"5","author":"Shah","year":"2014","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.prp.2023.154690_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.tig.2022.02.006","article-title":"Emerging concepts of miRNA therapeutics: from cells to clinic","author":"Diener","year":"2022","journal-title":"Trends Genet."},{"issue":"9","key":"10.1016\/j.prp.2023.154690_bib175","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.prp.2023.154690_bib176","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd4140","article-title":"MicroRNAs and other non-coding RNAs as targets for anticancer drug development","volume":"12","author":"Ling","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.prp.2023.154690_bib177","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/ERC-13-0098","article-title":"Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma","volume":"20","author":"Caramuta","year":"2013","journal-title":"Endocr. -Relat. Cancer"},{"issue":"10","key":"10.1016\/j.prp.2023.154690_bib178","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3390\/ph15101262","article-title":"Identification of novel cyanopyridones and pyrido [2, 3-D] pyrimidines as anticancer agents with dual VEGFR-2\/HER-2 inhibitory action: synthesis, biological evaluation and molecular docking studies","volume":"15","author":"Al-Warhi","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.prp.2023.154690_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154211","article-title":"Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase","volume":"240","author":"Ismail","year":"2022","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154690_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2020.108656","article-title":"Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase","volume":"160","author":"Ismail","year":"2020","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib181","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/14756366.2021.1901089","article-title":"Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers","volume":"36","author":"Kassab","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.prp.2023.154690_bib182","article-title":"Nanocomposite based on gold nanoparticles and carboxymethyl cellulose: synthesis, characterization, antimicrobial, and anticancer activities","volume":"77","author":"Doghish","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"46","key":"10.1016\/j.prp.2023.154690_bib183","doi-asserted-by":"crossref","first-page":"29052","DOI":"10.1039\/D1RA04345E","article-title":"Graphene oxide and its nanocomposites with EDTA or chitosan induce apoptosis in MCF-7 human breast cancer","volume":"11","author":"Doghish","year":"2021","journal-title":"RSC Adv."},{"issue":"16","key":"10.1016\/j.prp.2023.154690_bib184","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.3390\/polym14163352","article-title":"Synthesis of silver nanocomposite based on carboxymethyl cellulose: antibacterial, antifungal and anticancer activities","volume":"14","author":"Salem","year":"2022","journal-title":"Polymers"},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib185","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/14756366.2021.2015343","article-title":"New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies","volume":"37","author":"Elkady","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"5","key":"10.1016\/j.prp.2023.154690_bib186","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.coi.2007.05.004","article-title":"Bcl-2-regulated apoptosis: mechanism and therapeutic potential","volume":"19","author":"Adams","year":"2007","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib187","first-page":"1","article-title":"MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines","volume":"11","author":"Li","year":"2021","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.prp.2023.154690_bib188","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1080\/14728222.2017.1381087","article-title":"Fatty acid synthase (FASN) as a therapeutic target in breast cancer","volume":"21","author":"Menendez","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"issue":"3","key":"10.1016\/j.prp.2023.154690_bib189","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3390\/vaccines11030644","article-title":"Survivin (BIRC5) peptide vaccine in the 4T1 murine mammary tumor model: a potential neoadjuvant T cell immunotherapy for triple negative breast cancer: a preliminary study","volume":"11","author":"Burkholz","year":"2023","journal-title":"Vaccines"},{"issue":"12","key":"10.1016\/j.prp.2023.154690_bib190","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/ncb1998","article-title":"The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs","volume":"11","author":"Wellner","year":"2009","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.prp.2023.154690_bib191","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1634\/theoncologist.2018-0849","article-title":"microRNA\u2010431 as a chemosensitizer and potentiator of drug activity in adrenocortical carcinoma","volume":"24","author":"Kwok","year":"2019","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.prp.2023.154690_bib192","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/iep.12267","article-title":"MiR\u2010193a\u20103p functions as a tumour suppressor in human aldosterone\u2010producing adrenocortical adenoma by down\u2010regulating CYP 11B2","volume":"99","author":"Zhang","year":"2018","journal-title":"Int. J. Exp. Pathol."},{"issue":"1\u20132","key":"10.1016\/j.prp.2023.154690_bib193","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mce.2003.10.011","article-title":"The regulation of aldosterone synthase expression","volume":"217","author":"Bassett","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"10.1016\/j.prp.2023.154690_bib194","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2023.154690_bib195","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.toxlet.2015.11.009","article-title":"miRNA-200c mediates mono-butyl phthalate-disrupted steroidogenesis by targeting vimentin in Leydig tumor cells and murine adrenocortical tumor cells","volume":"241","author":"Lu","year":"2016","journal-title":"Toxicol. Lett."},{"issue":"7","key":"10.1016\/j.prp.2023.154690_bib196","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1210\/en.2012-1048","article-title":"Ablation of vimentin results in defective steroidogenesis","volume":"153","author":"Shen","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.prp.2023.154690_bib197","article-title":"Carnosine and crocin ameliorate oxidative stress in rats with rhabdomyolysis-induced acute kidney injury through upregulating HO-1 gene expression","volume":"49","author":"El-Ashmawy","year":"2022","journal-title":"Food\u00a0Biosci."},{"issue":"10","key":"10.1016\/j.prp.2023.154690_bib198","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1210\/jc.2018-00746","article-title":"miRNA-203 modulates aldosterone levels and cell proliferation by targeting Wnt5a in aldosterone-producing adenomas","volume":"103","author":"Peng","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.prp.2023.154690_bib199","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/HYPERTENSIONAHA.113.01102","article-title":"MicroRNA-24 is a novel regulator of aldosterone and cortisol production in the human adrenal cortex","volume":"62","author":"Robertson","year":"2013","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.prp.2023.154690_bib200","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1530\/EJE-10-1085","article-title":"Gene expression profiles in aldosterone-producing adenomas and adjacent adrenal glands","volume":"164","author":"Wang","year":"2011","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.prp.2023.154690_bib201","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.marpolbul.2014.04.002","article-title":"Regulation of CYP11B1 and CYP11B2 steroidogenic genes by hypoxia-inducible miR-10b in H295R cells","volume":"85","author":"Nusrin","year":"2014","journal-title":"Mar. Pollut. Bull."},{"issue":"5","key":"10.1016\/j.prp.2023.154690_bib202","first-page":"347","article-title":"Antisense oligonucleotides: basic concepts and mechanisms","volume":"1","author":"Dias","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.prp.2023.154690_bib203","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nature04303","article-title":"Silencing of microRNAs in vivo with \u2018antagomirs\u2019","volume":"438","author":"Krutzfeldt","year":"2005","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.prp.2023.154690_bib204","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nmeth1079","article-title":"MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells","volume":"4","author":"Ebert","year":"2007","journal-title":"Nat. Methods"},{"issue":"5848","key":"10.1016\/j.prp.2023.154690_bib205","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1147535","article-title":"Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430","volume":"318","author":"Choi","year":"2007","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.prp.2023.154690_bib206","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ijc.31363","article-title":"MiR\u2010483\u20135p and miR\u2010139\u20135p promote aggressiveness by targeting N\u2010myc downstream\u2010regulated gene family members in adrenocortical cancer","volume":"143","author":"Agosta","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.prp.2023.154690_bib207","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrd.2015.13","article-title":"Epithelial\u2013mesenchymal transition: a new target in anticancer drug discovery","volume":"15","author":"Marcucci","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.prp.2023.154690_bib208","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1096\/fj.09-151464","article-title":"The N\u2010myc downstream regulated gene (NDRG) family: diverse functions, multiple applications","volume":"24","author":"Melotte","year":"2010","journal-title":"FASEB J."},{"issue":"23","key":"10.1016\/j.prp.2023.154690_bib209","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.prp.2023.154690_bib210","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1007\/s13577-022-00778-2","article-title":"MicroRNA-149-3p expression correlates with outcomes of adrenocortical tumor patients and affects proliferation and cell cycle progression of H295A adrenocortical cancer cell line","volume":"35","author":"da Silva","year":"2022","journal-title":"Hum. Cell"},{"key":"10.1016\/j.prp.2023.154690_bib211","article-title":"Aberrant activation of Wnt\/\u03b2-Catenin signaling pathway drives the expression of poor prognosis-associated microRNAs in adrenocortical cancer with a major impact on miR-139\u20135p and its host gene PDE2A","author":"Cristante","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.prp.2023.154690_bib212","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.3c00013","article-title":"Implication of Wnt\/GSK-3\u03b2\/\u03b2-catenin signaling in the pathogenesis of mood disturbances associated with hyperthyroidism in rats: potential therapeutic effect of naringin","author":"Abd-Elmawla","year":"2023","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.prp.2023.154690_bib213","doi-asserted-by":"crossref","first-page":"73","DOI":"10.55705\/cmbr.2022.365396.1085","article-title":"MicroRNAs; their therapeutic and biomarker properties","volume":"3","author":"Azizi Dargahlou","year":"2023","journal-title":"Cell., Mol. Biomed. Rep."},{"issue":"7","key":"10.1016\/j.prp.2023.154690_bib214","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/cancers12071852","article-title":"A comprehensive review of cancer MicroRNA therapeutic delivery strategies","volume":"12","author":"Forterre","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.prp.2023.154690_bib215","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/cge.14256","article-title":"Dynamic interplay of microRNA in diseases and therapeutic","volume":"103","author":"Kargutkar","year":"2023","journal-title":"Clin. Genet."},{"key":"10.1016\/j.prp.2023.154690_bib216","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.actbio.2022.11.016","article-title":"A miRNA-based gene therapy nanodrug synergistically enhances pro-inflammatory antitumor immunity against melanoma","volume":"155","author":"Ma","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.prp.2023.154690_bib217","doi-asserted-by":"crossref","unstructured":"A.R. Glover, J.T. Zhao, A.J. Gill, J. Weiss, N. Mugridge, E. Kim, A.L. Feeney, J.C. Ip, G. Reid, S.J.O. Clarke, MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma, 6(34) (2015) 36675.","DOI":"10.18632\/oncotarget.5383"},{"key":"10.1016\/j.prp.2023.154690_bib218","doi-asserted-by":"crossref","unstructured":"T.D. Woiski, L. de Castro Poncio, J. de Moura, A. Orsato, A.G. Bezerra-Jr, J.C. Minozzo, B.C. de Figueiredo, Anti-hMC2RL1 functionalized gold nanoparticles for adrenocortical tumor cells targeting and imaging, 13(1) (2017) 68\u201376.","DOI":"10.1166\/jbn.2017.2331"},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib219","first-page":"284","article-title":"Synthetic high-density lipoprotein nanoparticles: A novel therapeutic strategy for adrenocortical","volume":"159","author":"Subramanian","year":"2016","journal-title":"carcinomas"},{"issue":"1","key":"10.1016\/j.prp.2023.154690_bib220","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/SLA.0b013e3182402d21","article-title":"Preclinical investigation of nanoparticle albumin-bound paclitaxel as a potential treatment for adrenocortical cancer","volume":"255","author":"Demeure","year":"2012","journal-title":"Ann. Surg."},{"key":"10.1016\/j.prp.2023.154690_bib221","article-title":"Stimuli-responsive hydrogels: smart state of-the-art platforms for cardiac","author":"El-Husseiny","year":"2023","journal-title":"Tissue Eng."},{"key":"10.1016\/j.prp.2023.154690_bib222","doi-asserted-by":"crossref","DOI":"10.1016\/j.apmt.2022.101560","article-title":"Smart\/stimuli-responsive hydrogels: state-of-the-art platforms for bone tissue engineering","author":"El-Husseiny","year":"2022","journal-title":"Appl. Mater. Today"},{"issue":"7","key":"10.1016\/j.prp.2023.154690_bib223","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3390\/pharmaceutics15071906","article-title":"Comparison of bovine- and porcine-derived decellularized biomaterials: promising platforms for tissue engineering applications","volume":"15","author":"El-Husseiny","year":"2023","journal-title":"Pharmaceutics"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823003904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823003904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:50:00Z","timestamp":1774410600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823003904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":223,"alternative-id":["S0344033823003904"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154690","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential role of miRNAs in the pathogenesis of adrenocortical carcinoma \u2013 A focus on signaling pathways interplay","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154690","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154690"}}